| Literature DB >> 34433065 |
Miriam A Lynn1, Georgina Eden1, Feargal J Ryan1, Julien Bensalem2, Xuemin Wang3, Stephen J Blake1, Jocelyn M Choo4, Yee Tee Chern1, Anastasia Sribnaia1, Jane James1, Saoirse C Benson4, Lauren Sandeman5, Jianling Xie5, Sofia Hassiotis2, Emily W Sun6, Alyce M Martin6, Marianne D Keller7, Damien J Keating6, Timothy J Sargeant2, Christopher G Proud3, Steve L Wesselingh4, Geraint B Rogers4, David J Lynn8.
Abstract
Studies investigating whether there is a causative link between the gut microbiota and lifespan have largely been restricted to invertebrates or to mice with a reduced lifespan because of a genetic deficiency. We investigate the effect of early-life antibiotic exposure on otherwise healthy, normal chow-fed, wild-type mice, monitoring these mice for more than 700 days in comparison with untreated control mice. We demonstrate the emergence of two different low-diversity community types, post-antibiotic microbiota (PAM) I and PAM II, following antibiotic exposure. PAM II but not PAM I mice have impaired immunity, increased insulin resistance, and evidence of increased inflammaging in later life as well as a reduced lifespan. Our data suggest that differences in the composition of the gut microbiota following antibiotic exposure differentially affect host health and longevity in later life.Entities:
Keywords: antibiotics; gut; immunity; inflammaging; lifespan; longevity; metabolism; microbiota; recolonization; vaccine
Mesh:
Substances:
Year: 2021 PMID: 34433065 DOI: 10.1016/j.celrep.2021.109564
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423